BizNewsConnect

1,2 and 3: SRM kickstarts Phase-3 of COVAIN trials

SRM Hosp goes on to 3rd gear with COVAXIN trail

Needs 500 volunteers for 3rd phase of trials

KATTANKULATHUR, Tamil Nadu, Dec 12 (BNC Network) SRM Medical College Hospital and Research Centre (SRM MCHRC) has launched the 3rd phase of human testing of the COVAXIN trial after successfully completing two phases.

SRM MCHRC's Pro Chancellor (Academics) Dr. P. Sathyanarayanan said over 1,000 volunteers will be tested for the vaccine in the third phase.

Until now we have received 500 volunteers for the test. We will be taking in more volunteers till the end of December 2020. “We are trying our best to make this work, as it will be India's first indigenous vaccine," Dr Sathyanarayanan said.

"Any person above 18 years of age and had not suffered COVID19 illness in the past can participate as a volunteer in this trial. Pregnant women are excluded. The vaccine shot will be administered twice - 28 days apart," said Principal Investigator for COVAXIN, Dr. Satyajit Mahopatra. 

The hospital will be able to conduct the trial for 50 people a day. Once the process is successful, the vaccine will be approved on a fast track basis. SRM MCHRC is currently treating 21 COVID 19 patients and on average 80 people are screened for COVID19.

The first phase of human trials at SRM MCHRC began in July 2020 with 30 volunteers. The second phase was done in August in which 45 volunteers participated. In both these phases, the safety of the vaccine was ascertained. In the trial conducted at SRM hospital, none of the volunteers suffered any serious reactions except for mild fever and body ache.

"SRM MCHRC is the only private Medical College Hospital in Tamil Nadu to undertake this trial. The third phase is to assess the efficacy of the Vaccine in inducing immunogenicity in the human volunteer," said Dr.Lt Col Dr. A. Ravi Kumar, Pro Vice Chancellor (Medical and Health Sciences).

Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech, Hyderabad in the development of COVAXIN. SRM Medical College Hospital and Research Centre is the only private Medical College Hospital in Tamil Nadu to be selected to carry out all three phases of the COVAXIN trial. This vaccine has got the nod for human trials from the Drug Controller General of India.

"SRM MCHRC is well-equipped with various facilities to handle clinical trials such as COVID 19. It provides 24-hours emergency services and has well-qualified doctors and nurses," said Dr. A. Sundaram, Dean, SRM MCHRC

The hospital has so far treated 1400 COVID patients since April 2020. Both Allopathy and Siddha medicines in combination are used to treat COVID patients. SRM Medical College Hospital and Research Centre has been doing this under the able guidance of Chancellor Dr. T.R. Paarivendhar and Pro Chancellor (Academics) Dr. P. Sathyanarayanan.

Those wishing to volunteer for this clinical trial can call 7598951868, 7358026002, 044-47432341 or email to srm.covaxin2020@gmail.com.

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Picture Caption:

SRM MCHRC's Pro Chancellor (Academics) Dr. P. Sathyanarayanan (fourth from left) kickstarts the Phase 3 of COVAXIN human trail at SRM Medical College Hospital and Research Centre (SRM MCHRC), Kattankulathur near Chennai, Tamil Nadu. Also seen with him are (L-R) SRM MCHRC's Director (Communication) Mr. R. Nandakummar, Principal Investigator for COVAXIN Dr. Satyajit Mahopatra, Pro Vice Chancellor (Medical and Health Sciences) Dr. Lt Col Dr. A. Ravi Kumar, Dean  Dr. A. Sundaram and Associate Dean (Research) Dr. Balasubramaniam.

 

 

Recent News

Advertisement